Preliminary Testing of New Treatment for Chronic Leg Wounds

Summary

The primary objectives of this study are to evaluate the efficacy, dosing, and safety of an intra-ulcer injection H5.020CMV.PDGF-b in adults who have a venous leg ulcer. The primary endpoint of this Phase I trial is the determination of the Maximum Tolerated Dose (MTD) for the intra-ulcer injection of H5.020CMV.PDGF-b.

Timeline

Start

2004-09

Primary completion

2008-08

Completion

2009-06

Drugs

Indications